Lunaphore is disrupting tissue diagnostics field by fundamentally changing the time and resource driven nature of diagnostic assays on tumor sections. Just like the fast sequencing technologies have made genomics testing possible for everybody today, Lunaphore will make possible an order-of-magnitude higher number of tissue biomarker checks for each tumor.
Lunaphore joins the Bio-Techne family (startupticker.ch)
Lunaphore announces acquisition by Bio-Techne, paving the way for advancements in spatial biology (venturelab.swiss)
Lunaphore secures CHF 40 million to boost portfolio of tissue diagnostics solutions (venturelab.swiss)
Lunaphore raises CHF40 million (startupticker.ch)
First US-based Contract Research Organization relies on Lunaphore (startupticker.ch)
Startups conquer bigger markets (startupticker.ch)
Lunaphore COMET European Deployment takes off (startupticker.ch)
New executives to drive innovation at deeptech startups (startupticker.ch)
On a growth path: Switzerland’s most promising scale-ups in 2021 (TOP 100)
Startups ink new partnerships (startupticker.ch)
Life science start-ups attract experienced board members (startupticker.ch)
Startups under new leadership (startupticker.ch)
25 most promising scale-ups in Switzerland (venturelab.swiss)
Die Finalisten des Swiss Economic Award stehen fest (startupticker.ch)
Lunaphore launches LabSat in four major markets (startupticker.ch)
How to strengthen the relationships with your suppliers and customers (venturelab.swiss)
Swiss Entrepreneurs Fund invests in Lunaphore (startupticker.ch)
Lunaphore Receives Additional CHF 2 million in Series C2 Financing (venturelab.swiss)
Lunaphore receives CHF 23M Series C financing (startupticker.ch)
TOP 100 Swiss Startup Lunaphore Raises CHF 23M in Series C Financing to Better Diagnose and Fight Cancer (venturelab.swiss)
Pitch Ata Tuna Ciftlik from Lunaphore @venture leaders kick-off event
venture leaders Interview with Ata Tuna Ciftlik from Lunaphore